Olopta 0.1% (Ophthalmic Solution)
5 ml drop: ৳ 100.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Olopatadine hydrochloride |
| Company | Gaco pharmaceuticals ltd |
| Also available as |
Product Title
- Patadin Eye Drops
- Olopta Nasal Spray
- Olopta Tablet
Categories
- Medicine
- Health & Wellness
- Eye Care
- Nasal Care
Description
- Indicated for the treatment of signs and symptoms of allergic conjunctivitis
- Relief of symptoms of seasonal allergic rhinitis
- Treatment of allergic rhinitis and allergic skin conditions
Color Options
- Transparent
- White
Functions
- Relieves itchy, watery, red, and swollen eyes
- Relieves nasal symptoms of allergies
- Relieves allergy symptoms such as skin rashes, swelling, hives, itching, sneezing, runny or stuffy nose
Materials
- Olopatadine
- Olopatadine hydrochloride
- Benzalkonium Chloride
- Soft Contact Lenses
Technical Specifications
- 0.1%, 0.2%, 0.7% concentration for eye drops
- 5 mg tablet dosage
- Intranasal administration for nasal spray
- Protein binding of olopatadine at approximately 55% in human serum
Design Elements
- Bottle design for eye drops
- Nasal spray container design
- Tablet shape and size
Usability Features
- Contact lens compatibility
- Primed nasal spray for fine mist
- Convenient dosing schedule
Pharmacological Action
- Mast cell stabilization
- Histamine H1 receptor antagonist with high selectivity
- Inhibition of inflammatory mediators and cytokines release
Mode of Action
- Stabilizes rodent basophils and human conjunctival mast cells
- Antagonist at the histamine H1 receptors
- Blocks the H1 receptor signaling pathway
Pharmacokinetics
- Peak plasma concentrations observed between 30 minutes and 1 hour after intranasal administration
- Moderate protein binding of olopatadine at approximately 55% in human serum
- Plasma elimination half-life of olopatadine is 8 to 12 hours
Dosage Instructions
- Different concentrations for eye drops with specific dosing intervals
- Variety of dosages based on age and symptoms
- Guidelines for missed doses
Administration Instructions
- Step-by-step guide for using nasal spray
- Cleaning instructions for nasal spray
- Contact lens usage precautions
Interaction
- No formal drug-drug interaction studies conducted for Olopta Nasal Spray
- Predominant elimination by renal excretion
Contraindications
- Known hypersensitivity to any component of the product
- Allergy to Olopatadine 5 mg tablet
Side Effects
- Rarely reported headaches
- Adverse effects like asthenia, blurred vision, burning or stinging, dry eye, pharyngitis, pruritus, taste perversion
Pregnancy & Lactation
- Not teratogenic in rats and rabbits
- Caution advised in pregnant women and nursing mothers
Precautions & Warnings
- Advice against wearing contact lenses if the eye is red
- Patient instructions for using nasal spray and tablets
- Consultation before stopping the medicine
Use in Special Populations
- No overall differences in safety or effectiveness observed
Overdose Effects
- No specific information on Olopta overdose
- Warning on excessive use of medication
Therapeutic Class
- Ophthalmic Non-Steroid drugs
Storage Conditions
- Room temperature storage
- Protection from light
- One month shelf life after opening
Related Brands
- OPT 0.7% (Ophthalmic Solution) - unido-pharmaceuticals-ltd
- Opatin 665 mcg/spray (Nasal Spray) - opsonin-pharma-ltd
- Olacing Max 0.7% (Ophthalmic Solution) - pacific-pharmaceuticals-ltd
- Olonex 5 mg (Tablet) - beacon-pharmaceuticals-plc
- Allet Max 0.7% (Ophthalmic Solution) - healthcare-pharmaceuticals-ltd